E-resources
PDF-
Smith, Kellie N; Llosa, Nicolas J; Cottrell, Tricia R; Siegel, Nicholas; Fan, Hongni; Suri, Prerna; Chan, Hok Yee; Guo, Haidan; Oke, Teniola; Awan, Anas H; Verde, Franco; Danilova, Ludmila; Anagnostou, Valsamo; Tam, Ada J; Luber, Brandon S; Bartlett, Bjarne R; Aulakh, Laveet K; Sidhom, John-William; Zhu, Qingfeng; Sears, Cynthia L; Cope, Leslie; Sharfman, William H; Thompson, Elizabeth D; Riemer, Joanne; Marrone, Kristen A; Naidoo, Jarushka; Velculescu, Victor E; Forde, Patrick M; Vogelstein, Bert; Kinzler, Kenneth W; Papadopoulos, Nickolas; Durham, Jennifer N; Wang, Hao; Le, Dung T; Justesen, Sune; Taube, Janis M; Diaz, Jr, Luis A; Brahmer, Julie R; Pardoll, Drew M; Anders, Robert A; Housseau, Franck
Journal for immunotherapy of cancer, 03/2019, Volume: 7, Issue: 1Journal Article
LAD is an inventor of licensed intellectual property related to technology for circulating tumor DNA analyses and mismatch repair deficiency for diagnosis and therapy (WO2016077553A1) from Johns Hopkins University. ...in the past 5 years, LAD has participated as a paid consultant for one-time engagements with Caris, Lyndra, Genocea Biosciences, Illumina and Cell Design Labs. J.R.B. is a consultant/advisory board member of BMS, Merck, Medimmune/AstraZeneca, Johnson and Johnson, Syndax, Celgene, Amgen, EliLilly. R.A.A. is a consultant/advisory board member for Bristol Myers Squibb, Merck, AstraZeneca, Adaptive Biotechnologies and has received research funding from Bristol Myers Squibb, Stand-up to Cancer and contractual work from Five Prime Therapeutics and FLX Bio.
